Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.
Article PubMed PubMed Central Google Scholar
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384(9951):1376–88.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–53.
Kurnit KC, Fleming GF, Lengyel E. Updates and new options in advanced epithelial ovarian Cancer treatment. Obstet Gynecol. 2021;137(1):108–21.
Article CAS PubMed Google Scholar
Shih IM, Wang Y, Wang TL. The origin of ovarian Cancer species and precancerous landscape. Am J Pathol. 2021;191(1):26–39.
Article CAS PubMed PubMed Central Google Scholar
Doherty JA, Peres LC, Wang C, Way GP, Greene CS, Schildkraut JM. Challenges and opportunities in studying the epidemiology of ovarian Cancer subtypes. Curr Epidemiol Rep. 2017;4(3):211–20.
Article PubMed PubMed Central Google Scholar
Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian Cancer study group. J Clin Oncol. 2012;30(21):2654–63.
Article CAS PubMed PubMed Central Google Scholar
Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121(13):2108–20.
Morch LS, Lokkegaard E, Andreasen AH, Kruger-Kjaer S, Lidegaard O. Hormone therapy and ovarian cancer. JAMA. 2009;302(3):298–305.
Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' health studies. Fertil Steril. 2014;102(1):192–8 e3.
Article PubMed PubMed Central Google Scholar
Melamed A, Rauh-Hain JA, Gockley AA, Nitecki R, Ramirez PT, Hershman DL, et al. Association between overall survival and the tendency for Cancer programs to administer neoadjuvant chemotherapy for patients with advanced ovarian Cancer. JAMA Oncol. 2021;7(12):1782–90.
Stewart C, Ralyea C, Lockwood S. Ovarian Cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–6.
McMullen M, Karakasis K, Rottapel R, Oza AM. Advances in ovarian cancer, from biology to treatment. Nat Can. 2021;2(1):6–8.
Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I, et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 2010;291(1):59–66.
Article CAS PubMed Google Scholar
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341–52.
Article PubMed PubMed Central Google Scholar
Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol. 1982;95(1):333–9.
Article CAS PubMed Google Scholar
Derynck R, Weinberg RA. EMT and Cancer: more than meets the eye. Dev Cell. 2019;49(3):313–6.
Article CAS PubMed PubMed Central Google Scholar
Hanahan D. Hallmarks of Cancer: new dimensions. Cancer Discov. 2022;12(1):31–46.
Article CAS PubMed Google Scholar
Matsumoto T, Yokoi A, Hashimura M, Oguri Y, Akiya M, Saegusa M. TGF-beta-mediated LEFTY/Akt/GSK-3beta/snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas. Mol Carcinog. 2018;57(8):957–67.
Article CAS PubMed Google Scholar
Amoroso MR, Matassa DS, Agliarulo I, Avolio R, Lu H, Sisinni L, et al. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis. 2016;7(12):e2522.
Article CAS PubMed PubMed Central Google Scholar
Chen Y, Wang DD, Wu YP, Su D, Zhou TY, Gai RH, et al. MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells. Br J Cancer. 2017;117(8):1192–201.
Article CAS PubMed PubMed Central Google Scholar
Fang D, Chen H, Zhu JY, Wang W, Teng Y, Ding HF, et al. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways. Oncogene. 2017;36(11):1546–58.
Article CAS PubMed Google Scholar
Zhao M, Liu Y, Zheng C, Qu H. dbEMT 2.0: an updated database for epithelial-mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis. J Genet Genomics. 2019;46(12):595–7.
Zhao M, Kong L, Liu Y, Qu H. dbEMT: an epithelial-mesenchymal transition associated gene resource. Sci Rep. 2015;5:11459.
Article PubMed PubMed Central Google Scholar
Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214–20.
Article CAS PubMed PubMed Central Google Scholar
Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CGM. Time-varying covariates and coefficients in cox regression models. Ann Transl Med. 2018;6(7):121.
Article PubMed PubMed Central Google Scholar
Tibshirani R. The lasso method for variable selection in the cox model. Stat Med. 1997;16(4):385–95.
Article CAS PubMed Google Scholar
Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–82.
Article CAS PubMed PubMed Central Google Scholar
Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, et al. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012;72(14):3499–511.
Article CAS PubMed PubMed Central Google Scholar
Li QJ, Wang J, Jiang J, Lin B. Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancer. J Ovarian Res. 2022;15(1):106.
Article CAS PubMed PubMed Central Google Scholar
Wu X, Li S, Chen D, Zheng G, Zhang Z, Li Z, et al. An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia. Am J Transl Res. 2022;14(7):4898–917.
CAS PubMed PubMed Central Google Scholar
Wang W, Pan F, Lin X, Yuan J, Tao C, Wang R. Ferroptosis-related hub genes in hepatocellular carcinoma: prognostic signature, immune-related, and drug resistance analysis. Front Genet. 2022;13:907331.
Article CAS PubMed PubMed Central Google Scholar
Zhang Y, Cao L, Nguyen D, Lu H. TP53 mutations in epithelial ovarian cancer. Transl Cancer Res. 2016;5(6):650–63.
Article CAS PubMed Google Scholar
Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164(5):1511–8.
Shin SY, Rath O, Zebisch A, Choo SM, Kolch W, Cho KH. Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition. Cancer Res. 2010;70(17):6715–24.
留言 (0)